Table 4.
Summary of adverse events.
| Adverse events | PL + GE (N = 301) (n) | PL (N = 21) (n) | GE (N = 33) (n) | (N = 355) Total (%) |
|---|---|---|---|---|
| Loss of erectile function | 0 | 0 | 0 | |
| Decrease of erectile function (temporary) | 2 | 1 | 0 | 0.008 |
| Penile oedema | 0 | 0 | 0 | |
| Long-standing haematoma | 2 | 1 | 1 | 0.011 |
| Seroma | 2 | 0 | 0 | 0.005 |
| Dehiscence | 0 | 0 | N/A | |
| No increase in girth | 0 | N/A | 0 | |
| Fat loss (>30%) | 15 | N/A | 6 | 0.059 |
| Fat nodules, fat lumps | 1 | N/A | 1 | 0.005 |
| Fat migration | 1 | N/A | 0 | 0.003 |
| Sclerosing lipogranuloma | 0 | N/A | 0 | |
| Loss of sensation (mild) | 3 | 0 | 2 | 0.001 |
| Fibrosis | 0 | 0 | 0 | |
| Superficial infection | 1 | 0 | 1 | 0.005 |
| Deep infection | 0 | 0 | 0 | |
| Paradoxical penile shortening | 0 | 0 | N/A | |
| No increase in length | 0 | 0 | N/A | |
| Delayed wound healing | 3 | 1 | N/A | 0.011 |
| Penile deformity | 0 | 0 | 0 | |
| Penile asimmetry | 1 | N/A | 1 | 0.005 |
| Penile curvature | 0 | 0 | N/A | |
| Decreased erection angle (penile instability) | 1 | 1 | N/A | 0.005 |
| Hypertrophic wound scarring | 2 | 1 | N/A | 0.008 |
| Keloid | 1 | 0 | 0 | 0.003 |
| Scrotalization | 0 | 0 | 0 | |
| Disfiguring advancement of suprapubic hairy skin | 2 | 0 | N/A | 0.005 |
PL = Penile Lengthening; GE = Girth Enhancement; N/A = not applicable.